Kimberly Tableman joined Castor as Chief Clinical Development Officer and Anna Wozniak as Chief Financial & Development Officer.
AiCure has added the following new senior team members: Brian Jung as Chief Financial Officer; Lynne Rowlandas Chief Marketing Officer, Aaron Masino, PhD, as Senior Director of Digital Biomarker Development; Nina Tayloras Director, Strategic Partnerships; and Viren Kavia as Director, Strategic Partnerships.
Curavit Clinical Research announced the appointments of Jay Collier, as Chief Operating Officer, and Candice Del Rio, as Director of Clinical Operations.
uMotif announced Steve Rosenberg was appointed to CEO.
Worldwide Clinical Trials announced the appointment of Dr. Wolfram C.M. Dempke, as Vice President, Scientific Solutions, Hematology & Oncology.
Parexel announced the appointment of Stephen Pyke as the company’s Executive Vice President, Clinical Data and Digital Services.
Medable Inc. announced the hiring of Orlando Baeza as the company’s first chief marketing officer.
Anju Software hired a new Vice President of Operations, Michael Keens.
Futura Medical is partnering with OCT Clinical to run its FM71 study in Eastern Europe and the USA.
Remarque Systems’ platform is the industry’s first patented trail-audited real-time risk-based quality management system.
PHASTAR was announced as a joint winner of the 2021 Innovation in the Management of Clinical Data Award by the Association for Clinical Data Management.
Anju Software has been named by Gartner as a sample vendor in four categories in its 2021 Hype Cycle Life Sciences Research and Development report and Commercial Operations report.
Elligo Health Research was named winner of the 2021 Site Tank Award at Society for Clinical Research Site’s recent 2021 Global Site Solutions Summit for their virtual AI-powered clinical trial engagement assistant, Root.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Phase III Trial Data Show Subcutaneous Pembrolizumab as Noninferior to IV Keytruda
March 31st 2025Subcutaneous administration of pembrolizumab with chemotherapy demonstrated a nearly 50% reduction in patient chair and treatment room time while maintaining efficacy and safety endpoints compared to intravenous Keytruda.
Phase II ALPACA Trial Shows Lepodisiran Produces Significant, Sustained Lipoprotein(a) Reductions
March 31st 2025Eli Lilly’s lepodisiran, an investigational siRNA therapy, achieved significant and durable reductions in lipoprotein(a) levels, a major genetic risk factor for cardiovascular disease.